Preferred Label : necitumumab;

MeSH note : a fully human antibody that has similar antitumor potency as the chimeric cetuximab/Erbitux and might represent a safer therapeutic alternative in EGF receptor inhibition;

CISMeF synonym : IMC-11F8;

MeSH hyponym : IMC-11F8 monoclonal antibody; 11F8;

Is substance : O;

UNII : 2BT4C47RUI;

Details


Main resources

You can consult :


https://www.ema.europa.eu/medicines/human/EPAR/Portrazza
2016
false
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
necitumumab
necitumumab
drug approval
europe
carcinoma, non-small-cell lung
squamous cell cancer
antineoplastic combined chemotherapy protocols
adult
infusions, intravenous
survival analysis
risk management
drug monitoring
Locally Advanced Malignant Neoplasm
neoplasm metastasis
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
necitumumab
Tyrosine Kinase Inhibitors
neoplasms, squamous cell
antibodies, monoclonal
antibodies, monoclonal
ErbB Receptors

---
Nous contacter.
20/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.